Red X iconGreen tick iconYellow tick icon

Will TaylorWill Taylor trained in rheumatology and rehabilitation medicine, obtaining vocational registration in these areas in 1998. He continues to practise clinical medicine in Wellington and Gisborne, New Zealand. His PhD, partly based in Leeds UK, led to the widespread adoption of new classification criteria for the diagnosis of psoriatic arthritis. He also chaired the development of new ACR/EULAR classification criteria for gout. Between 2008 and 2017 he lead the Rehabilitation Teaching & Research Unit.

Will supervises research students and is actively involved in research in a variety of fields including vocational rehabilitation, goal-setting, outcome measurement and clinical trial methodology (especially in gout). He works in collaboration with a number of local and overseas researchers including the Australia and New Zealand Musculoskeletal Clinical Trials (ANZMUSC) network, AUT University, OMERACT (Outcome Measures in Rheumatology Clinical Trials), GRAPPA (Group for Research and Assessment in Psoriasis and Psoriatic Arthritis) and the ICF Research Centre. He has a particular interest in instrumentation, psychometrics and clinical epidemiology. A current research interest concerns response criteria following treatment for gout and classification criteria for gout.

Will teaches in REHB 704 Musculoskeletal Rehabilitation.

Email will.taylor@otago.ac.nz

Publications

Taylor, W. J., Tuffaha, H., Hawley, C., Peyton, P., Higgins, A. M., Scuffham, P. A., … Hansen, P., … Morton, R. L. (2023). Embedding stakeholder preferences in setting priorities for health research: Using a discrete choice experiment to develop a multi-criteria tool for evaluating research proposals. PLoS ONE, 18(12), e0295304. doi: 10.1371/journal.pone.0295304

Tabi-Amponsah, A. D., Stewart, S., Gamble, G., Doyle, A., Son, C.-N., Latto, K., Stamp, L., Taylor, W., … Dalbeth, N. (2023). Dual Energy Computed Tomography (DECT) urate volume predicts fulfillment of gout remission after two years of intensive urate-lowering therapy. Arthritis & Rheumatology, 75(Suppl. 9), 1037. doi: 10.1002/art.42700

Pierobon, A., Taylor, W., Siegert, R., Caya, R., Policastro, P., Soliño, S., … Darlow, B. (2023). Range of physical functions assessed by existing knee performance-based and self-reported outcome measures: A scoping review. Proceedings of the New Zealand Primary Health Care, General Practice & Rural Health Research Symposium. (pp. 20). Retrieved from https://www.otago.ac.nz/wellington/departments/primaryhealthcaregeneralpractice

Uhlig, T., Karoliussen, L. F., Sexton, J., Kvien, T. K., Haavardsholm, E. A., Taylor, W. J., & Hammer, H. B. (2023). Beliefs about medicines in gout patients: Results from the NOR-Gout 2-year study. Scandinavian Journal of Rheumatology, 52(6), 664-672. doi: 10.1080/03009742.2023.2213507

Tabi-Amponsah, A. D., Stewart, S., Hosie, G., Stamp, L. K., Taylor, W. J., & Dalbeth, N. (2023). Gout remission as a goal of urate-lowering therapy: A critical review. Pharmaceuticals, 16, 779. doi: 10.3390/ph16060779

Back to top